Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma

被引:0
|
作者
Arora, D. [1 ]
Mehta, Y. [1 ]
Trehan, N. [1 ]
机构
[1] Medanta Medicity, Medanta Inst Crit Care & Anaesthesiol, Sector 38, Gurgaon, Haryana, India
关键词
recombinant factor VII; mediastinal tumor; angiosarcoma;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sarcomatous lesions of the mediastinum usually present as aggressive and multicentre masses often attached to adjoining structures including heart and lungs. A forty one year male diagnosed with sarcomatous lesion in mediastinum presented for biopsy through mid-sternotomy later confirmed as angiosarcoma on histopathology. Patient bled excessively after surgery and required reopening of the chest. However, bleeding could not be controlled with reopening, blood products and packing of the mediastinal cavity. Bleeding could only be controlled by using recombinant activated factor VII as rescue therapy without any adverse effects.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 50 条
  • [1] Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass
    DiDomenico, RJ
    Massad, MG
    Kpodonu, J
    Navarro, RA
    Geha, AS
    CHEST, 2005, 127 (05) : 1828 - 1835
  • [2] Variation in the use of recombinant activated factor VII in critical bleeding
    Willis, C. D.
    Cameron, P. A.
    Phillips, L.
    INTERNAL MEDICINE JOURNAL, 2010, 40 (07) : 486 - 493
  • [3] Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery
    Barua, Anupama
    Rao, Vinay P.
    Ramesh, B. C.
    Barua, Biplab
    El-Shafei, Hussain
    JOURNAL OF BLOOD MEDICINE, 2011, 2 : 131 - 134
  • [4] Recombinant activated factor VII for perioperative bleeding
    Lopez B, Rodrigo
    Aeschlimann D, Nicolas
    Carvajal F, Claudia
    Lema F, Guillermo
    REVISTA MEDICA DE CHILE, 2009, 137 (06) : 837 - 843
  • [5] Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding
    Ho, AMH
    Dion, PW
    Karmakar, MK
    ANESTHESIOLOGY, 2003, 98 (04) : 1025 - 1026
  • [6] Management of bleeding emergencies: when to use recombinant activated Factor VII
    DeLoughery, TG
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (01) : 25 - 34
  • [7] Use of recombinant activated factor VII for bleeding in pancreatitis -: A case series
    Laffan, MA
    Tait, RC
    Blatny, J
    Espersen, K
    Grabowska, I
    Loch-Bakoñska, L
    Pauzkowska, A
    Stasiak-Pikula, E
    Michalska, G
    Wendon, J
    Piotrowska, K
    PANCREAS, 2005, 30 (03) : 279 - 284
  • [8] Use of recombinant activated factor VII for treatment and prophylaxis of major bleeding
    Henriques Vince, Flavio Augusto
    Nascimento Brandao, Maria Jose
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2009, 22 (03): : 171 - 178
  • [9] The use of recombinant activated factor VII in platelet-associated bleeding
    Franchini, Massimo
    Lippi, Giuseppe
    Guidi, Gian Cesare
    HEMATOLOGY, 2008, 13 (01) : 41 - 45
  • [10] Use of recombinant activated factor VII
    Reingardiene, Dagmara
    Lazauskas, Robertas
    MEDICINA-LITHUANIA, 2009, 45 (03): : 248 - 253